191 related articles for article (PubMed ID: 1724841)
1. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
[TBL] [Abstract][Full Text] [Related]
2. The value of immunohistochemistry in the differential diagnosis of endometrial carcinomas.
Dallenbach-Hellweg G; Lang-Avérous G; Hahn U
APMIS Suppl; 1991; 23():91-9. PubMed ID: 1715731
[TBL] [Abstract][Full Text] [Related]
3. [Primary squamous cell carcinomas of the endometrium. Clinico-pathologic data and histogenetic classification].
Horn LC; Bilek K
Zentralbl Pathol; 1993 Nov; 139(4-5):355-60. PubMed ID: 7510514
[TBL] [Abstract][Full Text] [Related]
4. Histopathology of functional and neoplastic changes in cervix and endometrium.
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1997; 81():240-4. PubMed ID: 9474876
[TBL] [Abstract][Full Text] [Related]
5. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
6. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
7. Endometrial metaplasias and reactive changes: a spectrum of altered differentiation.
Nicolae A; Preda O; Nogales FF
J Clin Pathol; 2011 Feb; 64(2):97-106. PubMed ID: 21126963
[TBL] [Abstract][Full Text] [Related]
8. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
9. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
10. Multidirectional differentiation of endometrial carcinoma with special reference to tumor aggressiveness evaluated by Ki-67 expression.
Ikawa S; Sano T; Furumoto H; Aono T
Gynecol Oncol; 1999 Mar; 72(3):323-30. PubMed ID: 10053102
[TBL] [Abstract][Full Text] [Related]
11. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
Zaino RJ; Kurman RJ
Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509
[TBL] [Abstract][Full Text] [Related]
12. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
Schmidt D; Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical studies on uterine tumors. I. Invasive squamous cell carcinomas of the cervix and their precursors.
Dallenbach-Hellweg G; Lang G
Pathol Res Pract; 1991 Jan; 187(1):36-43. PubMed ID: 1709284
[TBL] [Abstract][Full Text] [Related]
14. [Adenocarcinoma of the cervix uteri (immunohistochemistry, ultrastructure, differential diagnosis from adenocarcinoma of the adjacent organs].
Petrov SV; Raĭkhlin NT; Serre G; Smedts F
Arkh Patol; 1995; 57(5):47-53. PubMed ID: 8579496
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
Horn LC; Meinel A; Handzel R; Einenkel J
Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.
Chekmareva M; Ellenson LH; Pirog EC
Int J Gynecol Pathol; 2008 Oct; 27(4):547-54. PubMed ID: 18753965
[TBL] [Abstract][Full Text] [Related]
18. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
19. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
20. The significance of the pathologic findings in endometrial cancer.
Christopherson WM
Clin Obstet Gynaecol; 1986 Dec; 13(4):673-93. PubMed ID: 3024898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]